Type 1 diabetes in adults: diagnosis and management (update)Status:In development | In consultationProgramme:NICE guidelineConsultation end date: 19 May 2021Expected publication date: 21 July 2021
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesStatus:In developmentProgramme:Diagnostics guidanceExpected publication date: 13 April 2022
Diabetic retinopathy - ruboxistaurin [ID382]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Macular oedema (diabetic) - pegaptanib sodium [ID452]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Diabetes - buccal insulin [ID311]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Empagliflozin for reducing the risk of cardiovascular events in type 2 diabetes [ID1037]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Type 2 diabetes in adults: management (update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC